Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61K 31/5377 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2671614

This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

L'invention concerne des composés nouveaux de 2,3-dihydroimidazo[1,2-c]quinazoline, des compositions pharmaceutiques contenant de tels composés et l'utilisation de ces composés ou compositions pour l'inhibition de la phosphotidylinositol-3-kinase (PI3K) et le traitement de maladies associées à l'activité de la phosphotidylinositol-3-kinase (PI3K), en particulier pour le traitement de troubles hyperlifératifs et/ou de l'angiogenèse, en tant qu'agent unique ou en combinaison avec d'autres ingrédients actifs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2060268

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.